How is Prostate Cancer graded and what does the grade mean
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
How Prostate Cancer is Graded
Prostate cancer grading is a critical part of understanding your diagnosis because it helps predict how aggressive your cancer is and guides treatment decisions. Let me walk you through how this system works.
The Gleason Score: The Foundation of Grading
When a pathologist examines your prostate biopsy samples under a microscope, they look at the pattern of cancer cells. According to the NCCN Guidelines, this pattern is assigned a number from 1 to 5, called a Gleason pattern. However, patterns 1 and 2 are so rarely found that they're no longer used in practice—the lowest pattern number you'll typically see is 3.
Here's what the patterns mean:
- Pattern 3 = Cancer cells that look more like normal, healthy prostate tissue
- Pattern 4 = Cancer cells that look more abnormal
- Pattern 5 = Cancer cells that look very abnormal and aggressive
Why Two Numbers?
Most prostate biopsies contain more than one pattern of cancer cells. So doctors combine the two most common patterns into a single Gleason score:
- The first number represents the pattern that takes up the largest area of the biopsy sample
- The second number represents the pattern that accounts for the second-largest area
Example: If your biopsy shows mostly pattern 3 cells with some pattern 4 cells, your Gleason score would be 3+4 = 7.
Gleason scores range from 6 to 10, where:
- 6 = Lowest score (least aggressive)
- 7 = Intermediate-grade
- 8-10 = High-grade (more aggressive)
Grade Groups: Making Gleason Scores Easier to Understand
Because Gleason scores can be confusing (why is 6 the lowest when it seems like a medium number?), doctors now organize them into Grade Groups 1-5. This system is more intuitive:
| Grade Group | Gleason Score | Risk Level | |---|---|---| | 1 | 6 | Low risk | | 2 | 3+4=7 | Intermediate risk | | 3 | 4+3=7 | Intermediate risk (more serious than Grade 2) | | 4 | 8 | High risk | | 5 | 9-10 | Very high risk |
An Important Distinction
Notice that both Grade Group 2 and 3 have a Gleason score of 7, but Grade Group 3 is considered more serious. Why? Because in Grade Group 3, the first number is 4 (4+3), meaning the most abnormal cells make up the largest portion of the biopsy. In Grade Group 2 (3+4), the more normal-looking cells (pattern 3) are more prevalent.
What Your Grade Means
According to NCCN Guidelines, your grade helps estimate:
- How quickly the cancer might grow – Higher grades suggest faster growth
- Whether the cancer will spread – Higher grades are more likely to spread outside the prostate
- Your overall risk group – Combined with PSA level, tumor stage, and biopsy results, your grade helps place you into a risk category (very low, low, intermediate, high, or very high)
- Which treatment options are appropriate – Generally, patients with lower-grade cancers may need minimal or no treatment, while higher-grade cancers typically require more aggressive treatment
Important Context
Your grade is just one piece of the puzzle. Your doctors will also consider:
- Your PSA level (prostate-specific antigen blood test)
- Your tumor stage (how far the cancer has spread)
- How many biopsy cores contained cancer
- Your age and overall health
- Your life expectancy
All of these factors together determine your risk group and guide treatment recommendations.
Questions to Ask Your Doctor:
- What is my specific Gleason score and Grade Group?
- Based on my grade and other factors, what risk group am I in?
- How does my grade affect my treatment options?
- Are there any additional tests (like genomic classifiers) that could provide more information about my specific cancer?
- What does my grade mean for my long-term outlook?
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Source Guidelines
NCCN Guidelines for Patients: Prostate Cancer (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with diagnosis for Prostate Cancer patients
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: